| Gene symbol | env | Synonyms | None | Type of gene | protein coding |
| Chromosome | - | Map location | NC_001802.1 (5771..8341) | dbXrefs | |
| Description | Envelope surface glycoprotein gp160, precursor | ||||
| GTO ID | GTC1138 |
| Trial ID | NCT00001409 |
| Disease | Acquired Immunodeficiency Syndrome | HIV Infection |
| Altered gene | env |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | Gene transfer |
| Treatment | Syngeneic Gene-Modified CTL |
| Phase | Phase1 |
| Recruitment status | Completed |
| Title | A Phase I/II Pilot Study of the Safety of the Adoptive Transfer of Syngeneic Gene-Modified Cytotoxic T Lymphocytes in HIV Infected Identical Twins |
| Year | 1999 |
| Country | United States |
| Company sponsor | National Institute of Allergy and Infectious Diseases (NIAID) |
| Other ID(s) | 940206|94-I-0206 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||
|
|||||||||